Ahsan MZ, Zhao MJ, Shoaib RM, Zhang Y, Wang YX. Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence. Life Sci. 2021;285:119996. doi:10.1016/j.lfs.2021.119996
Pub Category: Pharmacology
Wolińska R, Kleczkowska P, de Cordé-Skurska A, et al. Nitric oxide modulates tapentadol antinociceptive tolerance and physical dependence. Eur J Pharmacol. 2021;907:174245. doi:10.1016/j.ejphar.2021.174245
Khalil F, Choi SL, Watson E, et al. Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old. J Pain Res. 2020;13:3107-3123. Published 2020 Nov 24. doi:10.2147/JPR.S269549
Carelli C, Freni F, Moretti M, Vignali C, Ballardini M, Morini L. A case report on fatal intoxication by tapentadol: Study of distribution and metabolism [published online ahead of print, 2021 May 12]. Forensic Sci Int. 2021;324:110825. doi:10.1016/j.forsciint.2021.110825
Homma M, Kokubun H, Okuwaki K, et al. Pharmacokinetic Analysis, Analgesic Effects, and Adverse Effects of Tapentadol in Cancer Patients with Pain. Biol Pharm Bull. 2020;43(6):1000?1006. doi:10.1248/bpb.b20-00084
Caraci F, Coluzzi F, Marinangeli F, et al. Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?. Curr Med Res Opin. 2020;36(6):1015?1024. doi:10.1080/03007995.2020.1748876
Romualdi P, Grilli M, Canonico PL, Collino M, Dickenson AH. Pharmacological rationale for tapentadol therapy: a review of new evidence. J Pain Res. 2019;12:1513?1520. Published 2019 May 16. doi:10.2147/JPR.S190160
Raffa RB, Elling C, Tzschentke TM. Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’. Adv Ther. 2018;35(10):1471?1484. doi:10.1007/s12325-018-0778-x
Faria J, Barbosa J, Moreira R, Queirós O, Carvalho F, Dinis-Oliveira RJ. Comparative pharmacology and toxicology of tramadol and tapentadol. Eur J Pain. 2018;22(5):827?844. doi:10.1002/ejp.1196
Zhang L, Yan X, Nobe S, Zannikos P, Etropolski M, Nandy P. Quantifying the Exposure of Tapentadol Extended Release in Japanese Patients with Cancer Pain and Bridging Tapentadol Pharmacokinetics Across Populations Using a Modeling Approach. Clin Drug Investig. 2017;37(3):273?283. doi:10.1007/s40261-016-0482-z